Catalysts for $JAZZ
11 tracked
Aug 4, 2026
earnings
Jazz Pharmaceuticals plc earnings
Jazz Pharmaceuticals plc
→
Aug 3, 2026
earnings
Jazz Pharmaceuticals plc earnings
Jazz Pharmaceuticals plc
→
May 5, 2026
earnings
Jazz Pharmaceuticals plc earnings
Jazz Pharmaceuticals plc
→
Apr 25, 2026
phase 2 initiation
Jazz Pharmaceuticals Plc — durvalumab (Phase II Trial Initiation)
durvalumab
→
Feb 27, 2026
approval
ZEPZELCA (LURBINECTEDIN) — FDA approval
lurbinectedin
→
Oct 2, 2025
approval
ZEPZELCA (LURBINECTEDIN) — FDA approval
lurbinectedin
→
Apr 30, 2025
approval
ZEPZELCA (LURBINECTEDIN) — FDA approval
lurbinectedin
→
Jul 28, 2023
approval
ZEPZELCA (LURBINECTEDIN) — FDA approval
lurbinectedin
→
Apr 1, 2022
approval
ZEPZELCA (LURBINECTEDIN) — FDA approval
lurbinectedin
→
Jun 15, 2020
approval
ZEPZELCA (LURBINECTEDIN) — FDA approval
lurbinectedin
→
NOT_YET_RECRUITING
phase readout
NCT07298408: Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study
Jazz Pharmaceuticals plc
→